Problems with survivorship care in Europe
9 Sep 2017
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care
PACIFIC trial of durvalumab for stage III NSCLC
Questioning the role of CT-scan in NSCLC post-surgery follow-up
Osimertinib suitable for first line EGFRm lung cancer
FLAURA study of osimertinib versus TKI for 1st line NSCLC
Follow-up on the IFCT-0302 trial
PACIFIC trial of durvalumab for lung cancer
Editor's Choice for August 2017
Editor's Choice for July 17
iManageCancer: Serious Games for Kids
Emerging targets for the treatment of lung cancer